Furthermore, we confirmed this hypothesis with experiments, supporting that ALDH1A3 null could facilitate prostate cancer cells in castrated condition via PI3K pathway, but could be rescued by PI3K pathway inhibitor. Here, ALDH1A3 is linked to prostate carcinoma.